Helicos loses a lap to Illumina in race for cheap genome sequencing
January 13, 2010 by MassDevice staff
San Diego-based Illumina unveils equipment to sequence the human genome for less than $10,000, dealing a blow to Helicos Biosciences Corp.
Illumina Inc. (NSDQ:ILMN) put some distance between itself and its competitors this week, as it revealed equipment capable of sequencingthe human genome for less than $10,000.
The San Diego-based company unveiled its HiSeq 2000 at the annual J.P. Morgan Health Care Conference in San Francisco, where CEO Jay Flatley said a Hong Kong-based genomics institute called BGI bought 128 of the $690,000 systems, according to the Wall Street Journal.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
- How to simplify consents
Navigation
NEWS
J&J's Synthes unit wins $16M ruling in patent fight with Globus Medical
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Aneurysm: Covidien touts pivotal study on Pipeline embolization device
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
ForSight Vision5 gets new CEO, closes $9.3M funding round
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
Diabetes: Echo Therapeutics sends pre-submission package to FDA for Symphony needle-free CGM
Echo Therapeutics initiates discussions with the FDA on the regulatory pathway for its Symphony non-...
Real-world results cast doubt on renal denervation for high blood pressure
Study results revealed in Europe this week cast doubt on the efficacy of renal denervation for...
